Literature DB >> 24462904

Behavioral assays with mouse models of Alzheimer's disease: practical considerations and guidelines.

Daniela Puzzo1, Linda Lee2, Agostino Palmeri1, Giorgio Calabrese3, Ottavio Arancio4.   

Abstract

In Alzheimer's disease (AD) basic research and drug discovery, mouse models are essential resources for uncovering biological mechanisms, validating molecular targets and screening potential compounds. Both transgenic and non-genetically modified mouse models enable access to different types of AD-like pathology in vivo. Although there is a wealth of genetic and biochemical studies on proposed AD pathogenic pathways, as a disease that centrally features cognitive failure, the ultimate readout for any interventions should be measures of learning and memory. This is particularly important given the lack of knowledge on disease etiology - assessment by cognitive assays offers the advantage of targeting relevant memory systems without requiring assumptions about pathogenesis. A multitude of behavioral assays are available for assessing cognitive functioning in mouse models, including ones specific for hippocampal-dependent learning and memory. Here we review the basics of available transgenic and non-transgenic AD mouse models and detail three well-established behavioral tasks commonly used for testing hippocampal-dependent cognition in mice - contextual fear conditioning, radial arm water maze and Morris water maze. In particular, we discuss the practical considerations, requirements and caveats of these behavioral testing paradigms.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Animal models; Behavior; Cognition; Memory

Mesh:

Year:  2014        PMID: 24462904      PMCID: PMC4014001          DOI: 10.1016/j.bcp.2014.01.011

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  318 in total

1.  Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP.

Authors:  A Kamal; A Almenar-Queralt; J F LeBlanc; E A Roberts; L S Goldstein
Journal:  Nature       Date:  2001-12-06       Impact factor: 49.962

2.  Estradiol facilitates performance as working memory load increases.

Authors:  H A Bimonte; V H Denenberg
Journal:  Psychoneuroendocrinology       Date:  1999-02       Impact factor: 4.905

3.  Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene.

Authors:  M C Chartier-Harlin; F Crawford; H Houlden; A Warren; D Hughes; L Fidani; A Goate; M Rossor; P Roques; J Hardy
Journal:  Nature       Date:  1991-10-31       Impact factor: 49.962

Review 4.  The cerebellum in the spatial problem solving: a co-star or a guest star?

Authors:  L Petrosini; M G Leggio; M Molinari
Journal:  Prog Neurobiol       Date:  1998-10       Impact factor: 11.685

5.  The ventral midline thalamus contributes to strategy shifting in a memory task requiring both prefrontal cortical and hippocampal functions.

Authors:  Thibault Cholvin; Michaël Loureiro; Raphaelle Cassel; Brigitte Cosquer; Karine Geiger; David De Sa Nogueira; Hélène Raingard; Laura Robelin; Christian Kelche; Anne Pereira de Vasconcelos; Jean-Christophe Cassel
Journal:  J Neurosci       Date:  2013-05-15       Impact factor: 6.167

Review 6.  Cerebellar contributions to instrumental learning.

Authors:  R Lalonde
Journal:  Neurosci Biobehav Rev       Date:  1994       Impact factor: 8.989

7.  Exposing rats to a predator impairs spatial working memory in the radial arm water maze.

Authors:  D M Diamond; C R Park; K L Heman; G M Rose
Journal:  Hippocampus       Date:  1999       Impact factor: 3.899

8.  Humans with hippocampus damage display severe spatial memory impairments in a virtual Morris water task.

Authors:  Robert S Astur; Laughlin B Taylor; Adam N Mamelak; Linda Philpott; Robert J Sutherland
Journal:  Behav Brain Res       Date:  2002-04-15       Impact factor: 3.332

9.  Subfield-specific increase in brain growth protein in postmortem hippocampus of Alzheimer's patients.

Authors:  J L Rekart; B Quinn; M-M Mesulam; A Routtenberg
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

10.  Altered performance characteristics in cognitive tasks: comparison of the albino ICR and CD1 mouse strains.

Authors:  Benjamin Adams; Thomas Fitch; Stephen Chaney; Robert Gerlai
Journal:  Behav Brain Res       Date:  2002-07-18       Impact factor: 3.332

View more
  52 in total

Review 1.  A systems approach to drug discovery in Alzheimer's disease.

Authors:  Michael Shelanski; William Shin; Soline Aubry; Peter Sims; Mariano J Alvarez; Andrea Califano
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 7.620

Review 2.  Bidirectional relationship between sleep and Alzheimer's disease: role of amyloid, tau, and other factors.

Authors:  Chanung Wang; David M Holtzman
Journal:  Neuropsychopharmacology       Date:  2019-08-13       Impact factor: 7.853

3.  A longitudinal multimodal in vivo molecular imaging study of the 3xTg-AD mouse model shows progressive early hippocampal and taurine loss.

Authors:  Samuel Chiquita; Mário Ribeiro; João Castelhano; Francisco Oliveira; José Sereno; Marta Batista; Antero Abrunhosa; Ana C Rodrigues-Neves; Rafael Carecho; Filipa Baptista; Catarina Gomes; Paula I Moreira; António F Ambrósio; Miguel Castelo-Branco
Journal:  Hum Mol Genet       Date:  2019-07-01       Impact factor: 6.150

4.  Rigor and reproducibility in rodent behavioral research.

Authors:  Maria Gulinello; Heather A Mitchell; Qiang Chang; W Timothy O'Brien; Zhaolan Zhou; Ted Abel; Li Wang; Joshua G Corbin; Surabi Veeraragavan; Rodney C Samaco; Nick A Andrews; Michela Fagiolini; Toby B Cole; Thomas M Burbacher; Jacqueline N Crawley
Journal:  Neurobiol Learn Mem       Date:  2018-01-04       Impact factor: 2.877

Review 5.  Rodent models for Alzheimer's disease drug discovery.

Authors:  Daniela Puzzo; Walter Gulisano; Agostino Palmeri; Ottavio Arancio
Journal:  Expert Opin Drug Discov       Date:  2015-04-30       Impact factor: 6.098

Review 6.  Improving the predictive value of interventional animal models data.

Authors:  Caroline J Zeiss
Journal:  Drug Discov Today       Date:  2014-11-04       Impact factor: 7.851

Review 7.  Age-Related Neurodegeneration Prevention Through mTOR Inhibition: Potential Mechanisms and Remaining Questions.

Authors:  Jordan B Jahrling; Remi-Martin Laberge
Journal:  Curr Top Med Chem       Date:  2015       Impact factor: 3.295

8.  Effects of Lipoxin A4 Pretreatment on Cognitive Function of Aged Rats after Global Cerebral Ischemia Reperfusion.

Authors:  Hui-Sheng Wu; Pei-Pei Guo; Zhao Jin; Xin-Yi Li; Xin Yang; Jan-Juan Ke; Yan-Lin Wang; Xiao-Bo Feng
Journal:  Curr Med Sci       Date:  2018-08-20

Review 9.  Animal Models of Psychosis in Alzheimer Disease.

Authors:  Josh M Krivinko; Jeremy Koppel; Alena Savonenko; Robert A Sweet
Journal:  Am J Geriatr Psychiatry       Date:  2019-05-17       Impact factor: 4.105

10.  Linagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Mitigates Cognitive Deficits and Pathology in the 3xTg-AD Mouse Model of Alzheimer's Disease.

Authors:  Jayasankar Kosaraju; R M Damian Holsinger; Lixia Guo; Kin Yip Tam
Journal:  Mol Neurobiol       Date:  2016-10-03       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.